PE investors entered 2025 hoping more benign conditions might facilitate deal activity. These did not materialise, and the opening months of 2026 were marked by even more uncertainty, notably around artificial intelligence disruption and escalating tensions in the Middle East. With external shocks hard to predict, investors must double-down on internal competencies they can control, being mindful of geographical and sectoral impacts on asset selection and focusing on risk mitigation, value creation, and exit planning. 

• Where is most of the liquidity coming from in private equity? 
• Regulations, labour, innovation – how are investors tackling AI?
• Which geographies represent a calculated risk in 2026? 
• How are GP-LP relations changing as investor bases become more diverse?

Japan looks set for another bumper fundraising year in 2026 as local managers raise ever larger sums. Meanwhile, global GPs continue to put down roots with several key hires over the past 12 months. Japan benefits from both a compelling investment narrative – driven by regulatory reforms, activist pressure, aging demographics – and an attractive recent exit record, with four consecutive years of increasing proceeds. The burning question is: How long can this magic formula last?

• What does past evolution in the competitive landscape say about the future?
• How are currency movements impacting perception of the Japan opportunity?
• Is succession planning at the domestic GP level being taken seriously?
• Has investor sentiment changed since the new government came in?

Continuation vehicles (CVs) have proliferated in private equity, generating liquidity for managers and pushing GP-led secondaries volume to record highs – and encouraging more capital providers to enter the space. Japanese GPs have yet to widely embrace the CV concept, but local LPs with international portfolios have exposure to it. Much of the scrutiny is happening at the LP level, with questions asked about how GPs are selecting assets, timing transactions, and structuring economic incentives. 

• Are CVs a near-term liquidity fix or a long-term structural trend? 
• What potential red flags should LPs look out for when asked to exit or roll? 
• Why are more Japanese GPs not taking advantage of appetite for CVs?
• How can secondaries be used for portfolio optimization and risk management?

Large-cap deal flow in Japan is notoriously lumpy, but investors are sold on the long-term potential of corporate divestments and take-private transactions. Concerns remain as to whether these opportunities are sufficient in number to satisfy immediate demand – from upwardly mobile domestic GPs as well as global big hitters – and what this means for valuations. Conviction to pursue certain deals depends in part on having the comfort and skillsets to address operational complexity and add value. 

• Is increased competition leading to unsustainably high valuations? 
• Has large-cap take-private deal flow lived up to expectations?
• What might make a carve-out opportunity too complicated to touch?
• Are noisy activist-related processes fuelling broader negativity in the market?

Strategic objectives, portfolio maturity, underperformance versus public benchmarks, and weak distributions – all are factors weighing on Japanese LPs as they consider private equity allocations. Striking the right balance in terms of risk and reward has arguably never been harder. A natural preference for defensive and diversified exposure is being tested by a recognition that mid-market value creators might deliver the best returns, a need to mitigate the j-curve, and a growing interest in open-ended structures.  

• To what extent are reduced distributions still straining budgets?
• How are macro factors impacting geographical and sectoral preferences?
• What are LPs doing to develop skillsets for direct investment?
• Are evergreen vehicles a good fit for Japanese institutional investors?

GP stakes investing has evolved from ad hoc arrangements with sovereign wealth funds seeking strategic footholds to a strategy in its own right with dedicated platforms that derive returns from manager income streams. As best practices have emerged around deal structures and valuations, investor interest has pushed from the large-cap into the mid-market space. For GPs, selling equity can be controversial but also potentially catalytic: enabling succession planning, supporting strategic initiatives, and institutionalising corporate capabilities.

• What is the primary motivation for selling a GP stake?
• How do investors assess the suitability of manager targets?
• What are the major challenges in structuring these deals?
• How are investors generating liquidity for LPs in GP stakes funds?
• Can GP stakes address Japan’s manager succession conundrum? 

The Tokyo Stock Exchange’s move to raise the qualification bar for small-cap IPOs threatens to make life difficult for domestic VCs at a time when distributions are already slow. Solid track records and deal pipelines can sustain investor interest, but managers are looking at what else they can do to identify and develop the best start-ups. Options range from leveraging relationships with universities and incubators to partnering with corporate VC units and global counterparts.

• Can sponsor-to-sponsor transactions via expansion fill the exit void?
• To what extent does artificial intelligence dominate investment pipelines? 
• How should investors go about forming international partnerships?
• What is the key to selling a Japan VC strategy to global LPs?